Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AnGes Inc

4563
Current price
51 JPY +2.02 JPY (+4.08%)
Last closed 49 JPY
ISIN JP3127700007
Sector Healthcare
Industry Biotechnology
Exchange Tokyo Stock Exchange
Capitalization 12 192 537 468 JPY
Yield for 12 month -40.00 %
1Y
3Y
5Y
10Y
15Y
4563
21.11.2021 - 28.11.2021

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of ischemic diseases. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and asthma; medical devices for the prevention of vascular medicine; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative research agreement with Osaka University. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan. Address: Saito Bio-Incubator, Ibaraki, Japan, 567-0085

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

96 718.45 JPY

P/E ratio

Dividend Yield

Current Year

+155 201 601 JPY

Last Year

+68 032 694 JPY

Current Quarter

+237 405 731 JPY

Last Quarter

+115 206 338 JPY

Current Year

-3 109 700 652 JPY

Last Year

-2 962 589 550 JPY

Current Quarter

-789 981 792 JPY

Last Quarter

-753 037 060 JPY

Key Figures 4563

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 632 476 913 JPY
Operating Margin TTM -1558.87 %
PE Ratio
Return On Assets TTM -20.43 %
PEG Ratio
Return On Equity TTM -38.33 %
Wall Street Target Price 96 718.45 JPY
Revenue TTM 528 548 883 JPY
Book Value 92.82 JPY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 143.1 %
Dividend Yield
Gross Profit TTM -27 391 209 JPY
Earnings per share -30.23 JPY
Diluted Eps TTM -30.23 JPY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 4563

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 4563

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 100:1
Payout Ratio
Last Split Date 26.12.2013
Dividend Date

Stock Valuation 4563

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 22.907
Price Sales TTM 23.0679
Enterprise Value EBITDA -0.762
Price Book MRQ 0.4623

Financials 4563

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4563

For 52 weeks

43.62 JPY 99.42 JPY
50 Day MA 56.99 JPY
Shares Short Prior Month
200 Day MA 58.9 JPY
Short Ratio
Shares Short
Short Percent